Health Canada has approved a vaccine to protect both infants and older adults from respiratory syncytial virus, or RSV.  The vaccine is manufactured by Pfizer and is given to pregnant people, who pass along immunity protection to their babies. A pregnant woman stands for a portrait in Dallas, Thursday, May 18, 2023. THE CANADIAN PRESS/AP-LM Otero
Health Canada has approved a vaccine to protect both infants and older adults from respiratory syncytial virus, or RSV.  The vaccine is manufactured by Pfizer and is given to pregnant people, who pass along immunity protection to their babies. A pregnant woman stands for a portrait in Dallas, Thursday, May 18, 2023. THE CANADIAN PRESS/AP-LM Otero
Pfizer says the vaccine, called Abrysvo, is also approved for adults aged 60 and older.
ARTICLE CONTINUES BELOW
ARTICLE CONTINUES BELOW
Another RSV vaccine for older adults, manufactured by GSK, was approved by Health Canada last August.
Although RSV usually causes cold-like symptoms and most people recover on their own, infants and seniors are at higher risk of developing serious infection in their lower respiratory tracts.
Health Canada records show that the new RSV vaccine was approved on Dec. 21, but Pfizer first announced it on Thursday.
This report by The Canadian Press was first published Jan. 4, 2024.
Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.
Anyone can read Conversations, but to contribute, you should be a registered Torstar account holder. If you do not yet have a Torstar account, you can create one now (it is free).
To join the conversation set a first and last name in your user profile.
Anyone can read Conversations, but to contribute, you should be a registered Torstar account holder. If you do not yet have a Torstar account, you can create one now (it is free).
To join the conversation set a first and last name in your user profile.
Sign in or register for free to join the Conversation